| Name | Title | Contact Details |
|---|
Jasper County Health Department is a Newton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Official tweets from XANGO (Because tweeting officially is so much more pleasant than tweeting unofficially...!)
The Victorian Department of Health & Human Services develops and delivers policies, programs and services that support and enhance the wellbeing of all Victorians.
At Baby+Company we want to change the world one birth at a time… We`re driven by a passion to expand women`s choices -to make what can feel like a choice between two extremes, hospital delivery and home birth, into a spectrum of options. Not because we don`t support these other models of care, but because for many women, neither feels like the right fit. So we`re building birth centers that celebrate the individuality of our families— through a model of care that brings together the centuries-old tradition of midwifery with the very best research, resources and data available today.
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.